Health insurers are covering between 61 percent and 74 percent of the costs of ivermectin, a treatment for parasites in humans and animals, despite guidance from the FDA that it should not be used to treat COVID-19.
Payer Policy Updates
Health New England is expanding federally mandated coverage of at-home COVID-19 tests to include its Medicare Advantage members.